| 000 | 01775 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250518005040.0 | ||
| 264 | 0 | _c20200303 | |
| 008 | 202003s 0 0 eng d | ||
| 022 | _a1365-2125 | ||
| 024 | 7 |
_a10.1111/bcp.13808 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDaviet, Florence | |
| 245 | 0 | 0 |
_aThrombotic microangiopathy associated with gemcitabine use: Presentation and outcome in a national French retrospective cohort. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _c02 2019 |
||
| 300 |
_a403-412 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadverse effects |
| 650 | 0 | 4 |
_aDeoxycytidine _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFrance _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aPharmacovigilance |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aThrombotic Microangiopathies _xchemically induced |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aRouby, Franck | |
| 700 | 1 | _aPoullin, Pascale | |
| 700 | 1 | _aMoussi-Francès, Julie | |
| 700 | 1 | _aSallée, Marion | |
| 700 | 1 | _aBurtey, Stéphane | |
| 700 | 1 | _aMancini, Julien | |
| 700 | 1 | _aDuffaud, Florence | |
| 700 | 1 | _aSabatier, Renaud | |
| 700 | 1 | _aPourroy, Bertrand | |
| 700 | 1 | _aGrandvuillemin, Aurélie | |
| 700 | 1 | _aGrange, Steven | |
| 700 | 1 | _aFrémeaux-Bacchi, Véronique | |
| 700 | 1 | _aCoppo, Paul | |
| 700 | 1 | _aMicallef, Joëlle | |
| 700 | 1 | _aJourde-Chiche, Noémie | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 85 _gno. 2 _gp. 403-412 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bcp.13808 _zAvailable from publisher's website |
| 999 |
_c29010983 _d29010983 |
||